Combination low-dose thalidomide and cyclosporine prophylaxis for acute graft-versus-host disease in a rat mismatched model

G. B. Vogelsang; M. C. Wells; G. W. Santos; T. L. Chen; A. D. Hess

Combination low-dose thalidomide and cyclosporine prophylaxis for acute graft-versus-host disease in a rat mismatched model

G. B. Vogelsang, M. C. Wells, G. W. Santos, T. L. Chen, A. D. Hess

School of Medicine

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Abstract

Thalidomide is best known as a potent teratogenic agent but has been used sporadically to treat a variety of immunologically mediated disorders. Recently, thalidomide has been shown to be an effective agent in both treating and preventing graft-v-host disease (GVHD) after bone marrow transplantation (BMT) in a rat major histocompatibility mismatched model. The present report describes our results using combination low-dose thalidomide and low-dose cyclosporine prophylaxis in this model of GVHD.

Original language	English (US)
Pages (from-to)	226-228
Number of pages	3
Journal	Transplantation proceedings
Volume	20
Issue number	2 SUPPL. 2
State	Published - 1988

ASJC Scopus subject areas

Surgery
Transplantation

Cite this

@article{0930b44a0e9142848396ac1b982eef31,

title = "Combination low-dose thalidomide and cyclosporine prophylaxis for acute graft-versus-host disease in a rat mismatched model",

abstract = "Thalidomide is best known as a potent teratogenic agent but has been used sporadically to treat a variety of immunologically mediated disorders. Recently, thalidomide has been shown to be an effective agent in both treating and preventing graft-v-host disease (GVHD) after bone marrow transplantation (BMT) in a rat major histocompatibility mismatched model. The present report describes our results using combination low-dose thalidomide and low-dose cyclosporine prophylaxis in this model of GVHD.",

author = "Vogelsang, {G. B.} and Wells, {M. C.} and Santos, {G. W.} and Chen, {T. L.} and Hess, {A. D.}",

year = "1988",

language = "English (US)",

volume = "20",

pages = "226--228",

journal = "Transplantation Proceedings",

issn = "0041-1345",

publisher = "Elsevier USA",

number = "2 SUPPL. 2",

}

TY - JOUR

T1 - Combination low-dose thalidomide and cyclosporine prophylaxis for acute graft-versus-host disease in a rat mismatched model

AU - Vogelsang, G. B.

AU - Wells, M. C.

AU - Santos, G. W.

AU - Chen, T. L.

AU - Hess, A. D.

PY - 1988

Y1 - 1988

N2 - Thalidomide is best known as a potent teratogenic agent but has been used sporadically to treat a variety of immunologically mediated disorders. Recently, thalidomide has been shown to be an effective agent in both treating and preventing graft-v-host disease (GVHD) after bone marrow transplantation (BMT) in a rat major histocompatibility mismatched model. The present report describes our results using combination low-dose thalidomide and low-dose cyclosporine prophylaxis in this model of GVHD.

AB - Thalidomide is best known as a potent teratogenic agent but has been used sporadically to treat a variety of immunologically mediated disorders. Recently, thalidomide has been shown to be an effective agent in both treating and preventing graft-v-host disease (GVHD) after bone marrow transplantation (BMT) in a rat major histocompatibility mismatched model. The present report describes our results using combination low-dose thalidomide and low-dose cyclosporine prophylaxis in this model of GVHD.

UR - http://www.scopus.com/inward/record.url?scp=0023945118&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023945118&partnerID=8YFLogxK

M3 - Article

C2 - 3284069

AN - SCOPUS:0023945118

SN - 0041-1345

VL - 20

SP - 226

EP - 228

JO - Transplantation Proceedings

JF - Transplantation Proceedings

IS - 2 SUPPL. 2

ER -

Combination low-dose thalidomide and cyclosporine prophylaxis for acute graft-versus-host disease in a rat mismatched model

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this